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ABSTRACT Amadori-modiﬁedproteins(AMPs)aretheproductsofnonenzymaticglycationformedbyreactionofreducingsug-
arswithprimaryamine-containingaminoacidsandcandevelopintoadvancedglycatedendproducts(AGEs),highlystabletoxic
compounds.AGEsareknowntoparticipateinmanyage-relatedhumandiseases,includingcardiovascular,neurological,and
liverdiseases.Themetabolismoftheseglycatedproteinsisnotyetunderstood,andthemechanismsthatreducetheiraccumula-
tion are not known so far. Here, we show for Escherichia coli that a conserved glycopeptidase (Gcp, also called Kae1), which is
encodedbynearlyeverysequencedgenomeinthethreedomainsoflife,preventstheaccumulationofAmadoriproductsand
AGEs.Usingmutants,weshowthatGcpdepletionresultsinaccumulationofAMPsandeventuallyleadstotheaccumulationof
AGEs.WedemonstratethatGcpbindstoglycatedproteins,includingpyruvatedehydrogenase,previouslyshowntobea
glycation-proneenzyme.OurexperimentsalsoshowthattheseverephenotypeofGcpdepletioncanberelievedundercondi-
tionsoflowintracellularglycation.Asglycatedproteinsareubiquitous,theinvolvementofGcpinthemetabolismofAMPsand
AGEsislikelytohavebeenconservedinevolution,suggestingauniversalinvolvementofGcpincellularagingandexplaining
theessentialityofGcpinmanyorganisms.
IMPORTANCE Glycatedproteins(Amadori-modiﬁedproteins[AMPs]andadvancedglycatedendproducts[AGEs])areknownto
participateinmanyage-relateddiseases.Theirexistenceinfast-growingorganismswasconsideredunlikely,astheirformation
wasassumedtobeslow.Yet,recentevidencedemonstratedtheirexistenceinbacteria,andourdatasuggestabacterialmecha-
nism that reduced their accumulation. We identify in Escherichia coli a protein, Gcp, which carries out this function. Gcp is con-
servedinalldomainsoflifeandisessentialinmanyorganisms.Althoughitwasannotatedasachaperonprotease,therewereno
experimentaldatatosupportthisfunction.Ourﬁndingsarecompatiblewiththeannotationandwillopenupstudiesofthebac-
terialmetabolismofglycatedproteins.Furthermore,thedatafromthebacterialsystemsmayalsobeinstrumentalinunder-
standingthemetabolismofglycatedproteins,includingtheirtoxicityinhumanhealthanddisease.
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O
-sialoglycoprotein endopeptidase (OSGEP), also called Gcp
(glycopeptidase), tops the list of “conserved hypothetical”
proteins, which were considered top priority targets for experi-
mental studies by Galperin and Koonin (1). This ubiquitous en-
zymeisoneoffewhighlyconservedproteinswhichareencodedby
every sequenced genome in the three domains of life, with the
exceptionofthehighlydegraded,organelle-likebacterialgenomes
ofCarsonellaruddiiandSulciamuelleri(2).Gcpwasﬁrstdescribed
asasecretedproteinofMannheimiahaemolytica(formerlyknown
as Pasteurella haemolytica), isolated from bovine pneumonia,
where it exhibits glycopeptidase activity speciﬁcity to O-sialic
acid-containing glycoproteins (3). However, the ubiquity of Gcp
homologs cannot be explained by this function, as sialic acids are
highly uncommon in organisms other than vertebrates (4).
There have been several other publications dealing with the
potential role of Gcp homologs. These homologs were found to
have an HSP70 actin-like folding and were therefore predicted to
be ATP-dependent proteases with chaperon activity (5), but no
suchfunctionwasdemonstratedforanyGcphomolog.InSaccha-
romyces cerevisiae, the Gcp homolog Kae1 was found to be part of
a complex involved in telomere uncapping and elongation (6, 7),
andtheGcphomologofthehyperthermophilicarchaeonPyrococ-
cus abyssi exhibits apurinic endonuclease activity in vitro (8).
These data suggest that Gcp is involved in DNA metabolism, also
supported by the ﬁnding that Gcp-depleted Escherichia coli cells
had modiﬁed nucleoids and that Gcp-deﬁcient yeast mitochon-
dria lose their mitochondrial DNA (9–11). These studies do not
provide direct evidence for the molecular function of GCP but
indicate that its function affects a broad range of physiological
activities.
Gcp therefore represents an evolutionary puzzle: could highly
similarandconservedproteins(2)havedivergedsomuchinfunc-
tion across the domains of life, without much divergence in se-
quence? Alternatively, it is possible that the most conserved roles
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thologs have multiple physiological roles.
We assumed that Gcp functions as a glycoprotein-related
chaperon protease, as suggested by bioinformatics, structural
analysis(5),andenzymaticglycopeptidaseactivity(3).Therefore,
we looked for a sugar-related pathway which is highly conserved
in evolution and important for the physiology of all cells. One
such conserved role is the handling of toxic glycation products
that accumulate in all organisms and are harmful to living cells.
On the basis of this assumption, we examined the possible role of
Gcp in the metabolism of glycated proteins (Amadori products
and advanced glycated end products [AGEs]).
Amadori-modiﬁed proteins (AMPs) are the products of non-
enzymatic glycation formed by the reaction of reducing sugars
with primary amine-containing amino acids in proteins. These
glycated proteins are formed via a multistep chemical reaction
known as an Amadori rearrangement and can further develop
into irreversible, highly stable compounds known as AGEs (12–
15).
AGEsparticipateinthepathophysiologyofseveralhumandis-
eases, including cardiovascular, neurological, and liver diseases
(16–19). As the formation rate of AGEs depends on the carbohy-
drateandoxygenconcentrations,conditionsofchronichypergly-
cemia and oxidative stress, such as diabetes, result in increased
accumulation of AGEs and consequent toxic effects (20).
TheformationofAGEswasshowntobeaslowprocess,taking
weeks to months. On the basis of this view, it was assumed that
only long-lived proteins are at potential risk for developing these
modiﬁcations and that nonenzymatic glycation of bacterial pro-
teinsisunlikely,duetotherelativelyshortgenerationtimeofmost
bacteria. However, in 2001, Mironova et al. provided the ﬁrst ev-
idence for the nonenzymatic glycation and presence of AGEs in
E. coli, a rapidly growing organism (21).
Here,weprovidegeneticandbiochemicalevidencethatafunc-
tion of Gcp is the metabolizing of glycated proteins (Amadori
products and AGEs). We show that upon Gcp depletion in an
E. coli mutant, growth rate is dramatically reduced and cells accu-
mulate highly active AMPs and subsequently AGEs. We further
show by immunoprecipitation that Gcp primarily binds glycated
proteins and characterize several candidate substrates, including
the elongation factor Tu and the pyruvate dehydrogenase (PDH)
complex, which was previously shown to be susceptible to car-
bonylation in E. coli (22). Moreover, we show a correlation be-
tween the internal level of glycation and the inhibitory effect of
Gcp depletion.
TheseﬁndingsindicateadirectinvolvementofGcpintheme-
tabolism of glycated proteins and support the predicted function
of Gcp as a glycoprotein-related chaperon protease. On the basis
oftheseﬁndings,wepresentamodelwhichiscompatiblewiththe
complexGcp-relatedphenotypesandsuggestaconservedrolefor
Gcp activity.
RESULTS
ConstructionandphysiologyofGcp-depletedE.coli.Inorderto
investigate the possible function of Gcp in the metabolism of gly-
cated proteins in E. coli, we constructed a strain in which Gcp
levels can be reduced. In this strain, the chromosomal ygjD gene,
codingforGcp,wasdeletedandcomplementedbythepresenceof
a low-copy-number plasmid carrying the ygjD coding sequence
undertheregulationofthearabinose-dependentpBADpromoter
(Fig. 1A) (see Materials and Methods). The bacteria grew nor-
mallyinthepresenceof0.2%arabinosebutnotinthepresenceof
glucose, which repressed the expression of Gcp. When the bacte-
rial cultures were diluted into glucose-containing medium, the
growth rate gradually declined, and growth was dramatically re-
duced after a time period equivalent to about six generations
(Fig. 1B). The viability of the bacteria during Gcp depletion was
monitored by plating on arabinose-containing LB plates. No re-
duction of viability was observed, demonstrating that the growth
inhibition of Gcp-depleted cells can be restored by activation of
ygjDexpression.Moreover,althoughtherewasnoincreaseintur-
bidity, there was an increase in cell number, suggesting that Gcp
depletion results in smaller bacteria. Indeed, using electron mi-
croscopy,wecouldshowthatGcp-depletedcellsaremuchsmaller
and spherical, resembling the phenotype of stationary-phase bac-
teria (Fig. 1C). It should be noted that previous reports also dem-
onstrated that Gcp depletion results in altered cell morphology
(11). Handford et al. observed under Gcp depletion an unusual
morphology, with a varied appearance mostly consisting of en-
largedcells.Thefactthatwesawonlysmallcellsmaybeexplained
by the use of different E. coli strains (MC4100 versus MG1655),
FIG1 Construction and growth phenotype of the Gcp-depleted strain. (A) Schematic representation of the Gcp-depleted strain. The chromosomal ygjD gene,
coding for Gcp, was deleted and complemented by a low-copy-number plasmid with an arabinose (Ara)-inducible ygjD allele. (B) Growth of the Gcp-depleted
strain in the presence of 0.2% arabinose or 0.2% glucose for activation or repression of ygjD expression (respectively). Growth was monitored by measuring
absorbance at 600 nm. (C) Scanning electron micrographs of wild-type and Gcp-depleted cells.
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ogy determination is affected under Gcp-restrictive conditions.
Accumulation of AMPs and AGEs in Gcp-depleted cells. In
ordertodeterminethelevelsofglycatedproteinsinwild-typeand
Gcp-depleted cells, lysates were extracted and further separated
into soluble proteins and low-molecular-weight compounds by
use of size exclusion chromatography. Proteins were separated by
SDS-PAGE, and the gels were stained either by Coomassie bril-
liantblue(fortotalproteins)orbysugar-speciﬁcsilverstainingof
diols (for glycated proteins) (23). The results presented in Fig. 2
indicate that some E. coli proteins showed a speciﬁc staining pat-
tern, demonstrating the steady state of glycated proteins under
these conditions. Reduction of Gcp levels did not signiﬁcantly
change the total protein pattern but resulted in an accumulation
of a subset of glycated proteins (Fig. 2A). Interestingly, the accu-
mulation of glycated proteins was observed mainly at the high-
molecular-massregion(~75to150kDa).Asthespectrumofpro-
teins in this size range is fairly limited in E. coli, it is possible that
these bands represent a mobility shift of lower-molecular-weight
proteins that was caused by glycation. In order to quantify the
levelsofglycatedproteins,weusedaperiodate-basedcolorimetric
assay speciﬁc for the quantiﬁcation of Amadori protein products
(23).TheresultsdemonstratethatGcpdepletionresultedinabout
2.5-fold accumulation of Amadori products in the puriﬁed pro-
tein fraction (Fig. 2B).
Amadori products are relatively unstable intermediates in the
process of protein glycation. However, these molecules can fur-
ther develop into the highly stable AGEs. The presence of AGEs
wasdeterminedbyAGE-speciﬁcﬂuorescence,withmeasurement
of emission at 440 nm upon excitation at 370 nm. We observed
that in lysates extracted from Gcp-depleted cells, there was a 60%
increase in the accumulation of AGEs relative to the levels in ly-
satesofnondepletedcells(Fig.2C).Lysateswerefurtherseparated
as before, and proteins and low-molecular-weight fractions were
examinedindividually.OurdatapresentedinFig.2Cdemonstrate
that the protein fraction derived from Gcp-depleted cells showed
about40%higherlevelsofAGEsthanthatderivedfromwild-type
cells, while in the low-molecular-weight fraction, the accumula-
tion of AGEs was 2.5-fold higher. These results demonstrate that
Gcp depletion results in accumulation of AGEs and that most of
the AGEs accumulate as low-molecular-weight compounds.
InordertoestablishtheoriginofAGEsaccumulateduponGcp
depletion, we examined the potential of the separated fractions
from wild-type and Gcp-depleted cells to form AGEs in vitro. The
kinetics of AGE formation was measured using AGE-speciﬁc ﬂu-
orescence at 30-min intervals during incubation at the E. coli
physiological temperature of 37°C. Under these conditions, puri-
ﬁed proteins extracted from the Gcp-depleted cells rapidly devel-
oped into AGEs and accumulation of AGEs continued for at least
2 h (Fig. 3B). On the other hand, proteins extracted from the
wild-type strain showed a reduced potential for development of
AGEs, and accumulation reached a low plateau after 30 min of
incubation (Fig. 3A). A kinetic analysis of AGE formation in the
low-molecular-weight fractions indicated that fractions derived
fromboththewild-typestrainsandtheGcp-depletedstrainsdem-
onstrated low potential for forming AGEs (Fig. 3E and F). The
formation of AGEs from AMPs is known to be oxidation depen-
dent. Indeed, in a control experiment with the most potent frac-
tion (a protein fraction from Gcp-depleted cells), addition of
2 mM dithiothreitol (DTT) resulted in a considerable decrease in
the rate of AGE formation (Fig. 3C). Moreover, addition of
50 mM aminoguanidine completely abolished AGE accumula-
FIG 2 Accumulation of glycated proteins and AGEs following Gcp depletion. Lysates were extracted from wild-type and Gcp-depleted cells and further
separated into proteins and low-molecular-mass compound fractions, as described in Materials and Methods. (A) Proteins were subjected to SDS-PAGE,
followed by staining with Coomassie brilliant blue for total proteins (c) or diol-speciﬁc silver stain for glycated proteins (s). (B) Quantiﬁcation of glycated
proteins by use of a periodate-based colorimetric assay. (C) AGE-speciﬁc ﬂuorescence (relative; excitation at 370 nm and emission at 440 nm) following Gcp
depletion in total lysates and in the fractions of puriﬁed proteins and low-molecular-weight (MW) compounds. The results represent three independent
experiments.
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essential for AGE formation (24) (Fig. 3D).
Search for potential Gcp substrates. The ﬁndings that Gcp
depletion results in accumulation of AMPs and subsequently
AGEs suggest a direct involvement of Gcp in their metabolism.
In order to capture potential Gcp substrates, we used a coim-
munoprecipitation assay. Since potential Gcp substrates accu-
mulate primarily in its absence (Fig. 2A) and since enzyme-
substrate interaction is generally too rapid to be captured by
coimmunoprecipitation, we constructed a “Gcp-Trap” strain,
an established method for substrate capturing (25, 26). The
method, previously used for identifying substrates of known
chaperon proteases, is based on the idea that mutations in the
active site can produce proteins that
bindthesubstratesbutlackcatalyticac-
tivity. The Gcp-Trap allele was con-
structed by changing the essential
metal-binding histidine residues at po-
sitions 111 and 115 to alanines in the
predicted metallopeptidase domain
(Fig. 4A). This modiﬁed allele was
cloned into a pBR322 vector with a se-
quence coding for a FLAG tag (27) at
the 5= end of the gene. The plasmid car-
rying the Gcp-Trap allele was intro-
duced into the strain deleted for the
chromosomal Gcp-coding gene, and
the culture was depleted of Gcp. The al-
lele coding for the Gcp-Trap strain did
not compensate for the depletion of the
chromosomal ygjD gene, demonstrat-
ing the importance of the metal-
binding domain for Gcp function.
When growth ceased, the cells were dis-
ruptedandtheinactiveGcpproteinwas
precipitated using an anti-FLAG aga-
rose resin, as described in Materials and
Methods. Total proteins, unbound and
bound fractions, were separated using
SDS-PAGE and stained with either
Coomassiebrilliantblueordiol-speciﬁc
silver stain for detection of glycated
proteins. The results shown in Fig. 4B
demonstrate that the Gcp-Trap strain
accumulated glycated proteins, similar
to the accumulation observed for the
nontagged Gcp-depleted strain, recon-
ﬁrming the importance of the metal-
binding site for enzymatic function.
Moreover, the proteins found to be
bound to Gcp-Trap were predomi-
nantly glycated polypeptides, and their
pattern was fairly similar to the pattern
of the subset of glycated proteins found
to accumulate upon Gcp depletion
(compare Fig. 4B and Fig. 2A).
The proteins bound to the Gcp-Trap
allele were separated by two-dimensional
(2D) PAGE chromatography, and 10 of
themost-prominentspotsthatwerevisu-
alized on the gel were identiﬁed using mass spectrometry. These
proteins included the cell division protein FtsZ, the F1- subunit
of the ATP synthase AtpD, and the elongation factor Tu (EF-Tu),
all of them essential proteins in E. coli. Moreover, all three com-
ponents of the pyruvate dehydrogenase (PDH) complex, AceE,
AceF, and Lpd, were also among the Gcp-trapped proteins
(Fig. 4C). These results are compatible with those obtained in the
high-throughput experiments performed by Butland et al. (28),
which found interaction between Gcp and both EF-Tu and AceE.
It should be noted that the locations of some of these proteins
differed from the theoretical location predicted by molecular
weight. FtsZ and AtpD appear to have higher molecular weights,
whileLpdandEF-Tuwerepresentinmultiplespots.Theseabnor-
FIG 3 Kinetic studies of AGE formation in proteins and in low-molecular-weight fractions. Samples
were kept at 37°C, and AGEs were monitored every 30 min for2hb ymeasurement of AGE-speciﬁc
ﬂuorescence. The emission spectrum from 400 nm to 480 nm upon excitation at 370 nm is presented.
Kinetics of AGE formation in the protein fractions (A and B) and low-molecular-weight fractions (E
and F) of wild-type and Gcp-depleted (gcp) strains, respectively. Effect of 2 mM DTT (C) or 100 mM
aminoguanidine (AG) (D) on the kinetics of AGE formation in the protein fractions extracted from
Gcp-depleted bacteria.
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modiﬁcation, probably involving glycation at some step.
Some of the potential substrates captured by Gcp-Trap were
previously shown to be subjected to carbonylation. PDH, EF-Tu,
and the ATP synthase subunits were modiﬁed in mammalian mi-
tochondria (29, 30), while PDH and EF-Tu were also found to be
carbonylated in E. coli (22).
The ﬁnding that FtsZ is glycated in Gcp-depleted cells is inter-
estingandcanexplainthemorphologychangesobservedtooccur
under Gcp depletion, as FtsZ is known to participate in septation
and to mediate cell wall biosynthesis by interaction with
peptidoglycan-modifying enzymes (31).
LowerlevelsofactivePDHcomplexinGcp-depletedcells.
ThelevelsofactivePDHcomplexwerefurtherinvestigatedand
compared between wild-type and Gcp-depleted cells. Active
complexes were partially puriﬁed using ultracentrifugation.
Under these conditions, only stable complexes precipitate, due
to their massive molecular weight. The PDH complex was vi-
sualized by SDS-PAGE, and the results indicate that there is a
60% decrease in the amount of stable PDH complex in lysates
from Gcp-depleted cells, compared with the amount for the
wild type (Fig. 5A and B). The precipitated complexes have
similar speciﬁc activities, as measured by monitoring the accu-
mulation of NADH in the presence of pyruvate and coenzyme
A for 60 s (Fig. 5C). These results indicate that a smaller
amount of stable PDH complex is found in Gcp-depleted cells
and suggest that Gcp is involved in pre-
serving the glycation-prone PDH com-
plex.
In order to determine whether the re-
duction in active PDH is physiologically
signiﬁcant, we measured the level of its
substrate, pyruvate. It was previously
shown that pyruvate accumulates in mu-
tants with inactive PDH (32), and there-
fore, an increase in pyruvate levels repre-
sents the inability of PDH to function.
Indeed,depletionofGcpresulteditanap-
proximately 2-fold accumulation of
pyruvate, compared to the level for wild-
typecells(Fig.5D),demonstratingthese-
vere physiological effects of reduction in
active PDH complexes.
The severity of the Gcp depletion
phenotype correlates with the level of
protein glycation. Our data suggest that
Gcp prevents accumulation of glycated
proteins. Therefore, we assumed that the
level of glycation will inﬂuence the sever-
ity of the effect of Gcp depletion, which
resultsindramaticgrowthratereduction.
This assumption could be tested by re-
ducing the intracellular levels of glycated
proteins, which is predicted to lessen the
effectofGcpdepletion.Unfortunately,no
known extracellular agent that can de-
crease glycation in E. coli is currently
available. However, it was reported by
Dimitrovaetal.(33)thatintracellulargly-
cation levels are dramatically reduced
when bacteria are grown in minimal M9 medium. We therefore
compared the growth rates of our Gcp depletion strain in rich LB
medium and minimal M9 medium in the presence of arabinose
(for activation of gcp expression) or glucose (for its repression).
Cultures were diluted to optical densities at 600 nm (OD600s) of
0.005 (106 cells/ml), and turbidity was monitored for 10 h. The
data presented in Fig. 6A demonstrate that when bacteria were
growninrichLBmedium,repressionofgcpexpressionresultedin
a dramatic reduction of growth rate after about six generations.
However, when bacteria were grown in M9 minimal medium to
comparablecellconcentrations,repressionofGcpexpressiondidnot
affect growth rate during that time course. Moreover, under Gcp
repressionconditions,thedepletedstrainsgrewatanincreasedratein
thenutrient-inferiorminimalmedium,leadingtoincreasedturbidity
after 8 h, in contrast to the growth phenotype observed under non-
repressing conditions.
TheseresultsindicatethatdepletionofGcphasareducedeffect
on growth rate under conditions that reduce glycation. However,
it is also possible that Gcp synthesis is not shut down in minimal
mediumasefﬁcientlyasinrichmedium.Thispossibilitywasruled
out by the experiment represented in Fig. 6B, showing that the
levels of gcp transcripts, measured by real-time PCR, are actually
even lower in minimal medium than in LB under repression con-
ditions. Thus, under repression conditions (in the presence of
glucose), the gcp transcript level of cells grown in LB medium was
reduced to about 35% of the normal expression level found in
FIG 4 Characterization of Gcp substrates by use of immunoprecipitation. Immunoprecipitation was
performed by the use of a strain containing an inactive, metal-binding-deﬁcient Gcp (Gcp-Trap).
Bacteria were grown as described for Fig. 1, and Gcp was depleted by the addition of glucose. When
growth stopped, the cells were lysed, and proteins were puriﬁed as described for Fig. 2 and subjected to
immunoprecipitation using an anti-FLAG resin as described in Materials and Methods. (A) Schematic
representationoftheGcp-Trapallele.Thepredictedzinc-bindinghistidineswerereplacedbyalanines,
and a FLAG tag was added to the 5= end. (B) SDS-PAGE of total proteins and of fractions bound and
unbound to the anti-FLAG resin, stained with Coomassie brilliant blue for total proteins or a diol-
speciﬁc silver stain for glycated proteins. (C) Separation of Gcp-suspected substrates on two-
dimensionalgelelectrophoresisgels.Proteinswereidentiﬁedbymassspectrometry,andproteinnames
are indicated next to each spot.
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transcriptlevelstolessthan10%ofthenormalexpressionlevel.In
viewofthisresult,showingreducedgcptranscriptlevelsyetnophys-
iologicaleffectsofGcpdepletion,wedeterminedthelevelsofAGEsin
the wild type and in the mutant in rich and minimal media. The
resultsshowninFig.6Cindicatethat,indeed,therearelowerlevelsof
glycationproductsinminimalmedium,asreportedbefore(33).Gcp
depletionresultedinanincreaseinthelevelofAGEseveninminimal
medium.However,thislevelwasstilllowerthanthelevelofAGEsin
the wild type grown in rich medium, in agreement with the lack of
phenotypic manifestation of Gcp depletion in minimal medium.
Taken together, these results demonstrate that although in
minimal medium there is less Gcp in depleted bacteria, the effect
of the depletion is less severe than in rich
medium. These results are compatible
with the hypothesis that the severe phe-
notype of Gcp depletion is due to accu-
mulation of glycated proteins.
DISCUSSION
On the basis of the data presented here,
our model (Fig. 7) suggests that Gcp is
directly involved in AMP metabolism
and that its depletion results in accumu-
lationofAMPs,whichserveasthepoten-
tial for development of AGEs. These
AGEs are probably further degraded in
thecell,astheyaccumulateinthefraction
of low-molecular-weight compounds.
The molecular mechanism of Gcp
function is not yet fully understood. One
possibilityisthatGcpisinvolvedinAma-
dori product neutralization by protein
degradation. This hypothesis is compati-
ble with the current annotation of Gcp as
a glycopeptidase, as was shown for
M. haemolytica (3). Another possibility is
that Gcp plays a role in recycling of pro-
teinsbyassistingdeglycationusingitspu-
tative chaperon activity (5).
Several enzymes, known collectively
as “amadoriases,” were found to have
deglycating activity, having the ability to
reverse nonenzymatic glycation by cleav-
ing the bond between amino acids and
corresponding sugars (34, 35). One such
enzyme, capable of deglycating fructosel-
ysine, was found in E. coli (36). These en-
zymes were shown to act only on low-
molecular-weight peptides and are
unable to work on proteins. Gcp may act
by introducing glycated proteins to ama-
doriases either by allowing access to the
sugar moiety on the full-length proteins
(using its predicted chaperon activity) or
bycleavingtheAmadoriproductinaway
thatwillenablebetteraccessofamadoria-
ses to the glycated peptides.
The mechanism which leads to cessa-
tion of cell growth after Gcp depletion is
likelytobethereasonfortheessentialityofGcpinseveralorganisms.
Our data suggest that Gcp depletion results in accumulation of gly-
cated protein products which cause growth arrest. Support for this
assumptionisobtainedbytheﬁndingthatGcpdepletionhasagreatly
reducedeffectongrowthunderconditionswhichreduceproteingly-
cation (Fig. 6). Accumulation of AMPs and AGEs can be potentially
toxic, as AGEs were found to increase cellular oxidative stress (37).
However, we found that addition of antioxidants such as lipoic acid,
ascorbic acid, or glutathione to the growth medium did not relieve
the Gcp depletion phenotypes. Another possibility is that glycated
proteins left untreated can cause metabolic dysfunction. Damaged
enzymes can be potentially toxic if they have a dominant negative
FIG 5 Partial puriﬁcation and activity measurements of the pyruvate dehydrogenase (PDH) complex
from wild-type and Gcp-depleted cells. Equal amounts of proteins from wild-type and Gcp-depleted
cells were centrifuged for the precipitation of the PDH complex. (A) SDS-PAGE of PDH puriﬁcation.
The complex components are indicated. (B) Relative quantiﬁcation of the amount of PDH complex
from three independent experiments. (C) In vitro activity measurement of the PDH complex from
wild-type and Gcp-depleted cells. The graph represents the accumulation of the reaction product
NADH by measuring its speciﬁc absorption at 339 nm. Speciﬁcity was validated by comparison to a
negative control lacking the substrate, pyruvate.
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leadingtoinactivationofcomplexes.Thisexplanationappearsprom-
ising, as all of the potential substrates of Gcp identiﬁed in this study
were parts of multimeric protein complexes.
In mammalian cells, the toxicity of AGEs is facilitated by their
interaction with speciﬁc receptors, soluble as well as membrane
bound.OurbioinformaticssearchsuggeststhattheE.coligenome
does not contain genes coding for homologs of these receptors. It
isstillpossiblethatadirectinteractionofAGEswithspeciﬁctarget
proteins is involved in the toxicity. Localization of such putative
complexes may shed light on their function but is complicated by
thefactsthattherearemanytypesofAGEsandthattheavailability
of antibodies is limited.
The downstream metabolism of AGEs should also be further in-
vestigated.WeshowthatahighfractionoftheAGEsispresentinthe
low-molecular-weight fraction. These low-molecular-weight AGEs
probably result from a proteolytic breakdown of modiﬁed proteins.
The enzymatic mechanism responsible for AGE degradation is cur-
rently unknown. Yet, we eliminated the possible participation of the
threemajorcytosolicATP-dependentproteases,asatriplemutantat
Lon, ClpX, and HslV still accumulates low-molecular-weight AGEs
whenGcpisdepleted.However,becauseinourgeneticsystemGcpis
not completely abolished, we cannot yet rule out the possibility that
Gcp is involved in AGE degradation.
Thespeciﬁcmoleculesthatleadtoproteinglycationinbacteria
are currently unknown. Since extracellular concentration of re-
ducing sugars did not correlate with intracellular glycation levels,
it was postulated that intracellular metabolic pathways are the
source of these agents (33). One potentially active agent shown to
be produced in E. coli is methylglyoxal, synthesized by the meth-
ylglyoxal synthase MgsA (38). However, deletion of msgA did not
relieve the Gcp depletion phenotypes, demonstrating that this
agentisnotadominantfactorinGcpmetabolicfunction(C.Katz
and E. Z. Ron, unpublished data).
FIG 6 Gcp depletion growth phenotype in rich LB medium and minimal M9 medium.
(A)TheGcp-depletedstrainwasgrowninthepresenceof0.2%arabinoseor0.2%glucose
for activation or repression of Gcp expression, respectively, in rich LB medium and
minimal M9 medium. The cells were diluted from arabinose-containing medium into
freshmediumsupplementedwitharabinoseorglucoseasindicatedtoaconcentrationof
106/ml, and growth was monitored for 10 h by measuring absorption at 600 nm. (B)
RelativeexpressionlevelsoftheGcp-depletedstraingrownunderdifferentconditionsas
indicated. Relative mRNA levels measured using real-time PCR are presented. The wild-
type expression level represents chromosomal gcp expression levels of wild-type cells
grown in LB medium. Wild-type expression levels were similar in both media and were
not signiﬁcantly altered by supplementation with either glucose or arabinose.
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venting accumulation of glycated proteins, which are ubiquitous
substrates in living cells. Thus, this metabolic function is likely to
extend to all domains of life and should also be tested for in Ar-
chaea and Eukarya. These ﬁndings open up the avenue for inves-
tigatingglycatedproteinsinbacteria,includingtheirmetabolism,
functions, and possible toxicity. The ability to study glycated pro-
teinsinaneasymodelorganism,suchasE.coli,whichisamenable
to genetic manipulation, will advance investigations of glycation
processes in ageing and in human diseases.
MATERIALS AND METHODS
Bacterial strains and plasmids. The strains
and plasmids used in this work are described
in Table 1.
Growth conditions. Bacteria were grown
in standard LB medium (Difco) or minimal
M9mediumat37°C.Themediumwassupple-
mented with arabinose or glucose at 0.2%.
Control strains were grown under the same
conditions as Gcp-depleted strains to reduce
the possible background of the sugar concen-
trations present in the growth media. Antibi-
otics were added when required at the follow-
ing concentrations: for ampicillin (Amp),
100 g/ml; for kanamycin (Km), 50 g/ml;
and for chloramphenicol (Cm), 25 g/ml.
Genetic manipulations. The chromo-
somalygjDgenewasdeleted,aspreviouslyde-
scribed (39), in the presence of the comple-
mentation plasmid pACYC:pBAD:ygjD. The
Gcp-Trap allele was constructed in two steps.
First, the ygjD open reading frame (ORF) and
promoter were ampliﬁed using the FLAG
epitope tag-containing primers and cloned
intoEcoRI-digestedpBR322.Second,thecon-
served metal-binding domain was manipu-
latedbyreplacingthetwoconservedhistidines
(positions111and115)withalaninesbyuseof
PCR-based site-directed mutagenesis.
Preparation of samples for determination
of Amadori products and AGEs. Lysates were
extracted using a Qproteome bacterial protein
preparatory kit (Qiagen) according to the manufacturer’s recommendation.
Thelysateswerefurtherseparatedintopuriﬁedproteinsandlow-molecular-
weight compounds by use of GE Healthcare HITRAP desalting columns,
equilibratedwitheitherphosphate-bufferedsaline(PBS)orH2OforAGEor
Amadoriproductanalysis,respectively,accordingtothemanufacturer’srec-
ommendation. These columns possess an exclusion limit of 5,000 g/mol of
globular compound; thus, compounds with lower molar masses are here
referredtoaslow-molecular-weightcompounds.Nucleicacidsweredigested
as part of the Qproteome extraction procedure and therefore were present
mostly in the low-molecular-weight fraction. Separations were performed
FIG 7 Schematic model of Amadori-modiﬁed proteins and AGE metabolism in E. coli. The model
suggests that Gcp participates in the metabolism of glycated proteins by reducing the level of Amadori
products, thereby decreasing the formation of AGEs. Once AGEs are formed, they are broken down to
smaller molecules.
TABLE 1 Strains and plasmids
Plasmid or strain Feature(s) Description, genotype, or reference(s)
Plasmids
pBAD24 Plasmid containing an arabinose-inducible promoter 44
pBAD:ygjD Ampr; arabinose-dependent ygjD expression pBAD24 with the ygjD ORF cloned after EcoRI and XbaI digestion
pACYC:pBAD:ygjD Cmr; low-copy-number plasmid for enhanced control of
ygjD expression
pBAD:ygjD digested with BspHI and cloned into pACYC184 digested
with the same enzyme
pBR322 45, 46
pBR322
Gcp-Trap
Ampr; constitutive expression of FLAG-tagged inactive
ygjD for immunoprecipitation
5= FLAG-tagged ygjD with its endogenous promoter cloned into an
EcoRI-digested PBR322 plasmid; the metal-binding histidine
residues at positions 111 and 115 were modiﬁed to alanines
Bacterial strains
K-12 MG1655 Wild type
K-12 MG1655
pACYC:pBAD:ygjD
Wild type carrying a plasmid with cloned inducible gcp K-12 MG1655 pACYC:pBAD:ygjD
Gcp depletion
strain
Used for Gcp depletion; the deletion is complemented by
an inducible ygjD gene on a plasmid
K-12 MG1655 ygjD pACYC:pBAD:ygjD
Gcp-Trap strain Used for Gcp immunoprecipitation; this is the Gcp
depletion strain with an additional plasmid coding for
a peptidase-deﬁcient Gcp protein
K-12 MG1655 ygjD pACYC:pBAD:ygjD pBR322 Gcp-Trap
Katz et al.
8 mbio.asm.org July/August 2010 Volume 1 Issue 3 e00195-10and evaluated using the Amersham AKTA Prime Plus fast-performance liq-
uid chromatography (FPLC) system.
Analysis of glycated proteins on SDS-PAGE gels. Proteins were ex-
tracted and puriﬁed as described above and separated using 10% SDS-
PAGE. The gels were stained using Coomassie brilliant blue staining for
totalproteinanalysisandusingdiol-speciﬁcsilverstainingasdescribedin
reference 23 for glycated-protein analysis. The Amadori product colori-
metric assay was preformed as described in reference 40.
Determination of AGEs. AGEs were quantiﬁed using AGE-speciﬁc
ﬂuorescencebyscanningemissionsrangingfrom400nmto480nmupon
excitationat370nmat37°CwithaHORIBAscientiﬁcFluoroLog-3spec-
troﬂuorometer. The data presented represent either the full-range spec-
trum or the 440-nm emission peak.
Gcp-Trap coimmunoprecipitation assay. The Gcp-Trap strain was
grownovernightinthepresenceofarabinoseanddiluted1/200intofresh
LB supplemented with 0.2% glucose. The culture was kept at logarithmic
ODs (0.2 to 0.8) by further dilutions until growth ceased. Twenty millili-
ters of culture at an OD600 of 0.4 was harvested and subjected to total
soluble protein puriﬁcation as described for the sample preparation. A
desalting stage was used for buffer replacement, and puriﬁed proteins
wereelutedinTris-bufferedsaline(TBS)buffer,pH7.4,followedbycon-
centrationto0.5mlusing10KAmiconUltra(Millipore).Thesamplewas
incubated overnight at 4°C with 50 l of anti-FLAG M2-agarose (Sigma)
prewashedwithTBS.Sampleswerewashedﬁvetimeswith1mlTBSbuffer
and eluted using 200 l TBS supplemented with 100 M3  FLAG pep-
tide (Sigma). Total proteins, unbound and bound fractions, were sub-
jected to SDS-PAGE and stained either with Coomassie brilliant blue or
with a diol-speciﬁc silver stain.
2D analysis and protein identiﬁcation. Fifty micrograms of proteins
obtained by Gcp-Trap coimmunoprecipitation assay was separated using
two-dimensionalgelelectrophoresiswith13-cmIPGstrips,pH4to7(GE
Healthcare), and identiﬁed using mass spectrometry, as described in ref-
erence 41.
Pyruvate dehydrogenase puriﬁcation and activity measurement.
Ten milliliters of wild-type and Gcp-depleted cultures at an OD600 of 0.4
was harvested, and the pellets were resuspended in 1 ml buffer (50 mM
K-phosphate,pH7.5,5mMEDTA,and2mMDTT)anddisruptedusing
sonication. Lysates were centrifuged for 30 min at 40,000  g for mem-
brane precipitation, and equal protein amounts of the membrane-free
supernatants were centrifuged again for 1.5 h at 150,000  g for PDH
precipitation. The PDH complexes were analyzed by SDS-PAGE as de-
scribed above. PDH activity was measured as described in reference 42.
Control reactions without pyruvate were used as a negative control for
background assessment.
Pyruvate measurements. Pyruvate extraction was based on the hot-
water method described in reference 43. Ten-milliliter samples at an
OD600 of 0.4 were collected and centrifuged, and the pellets were washed
withdistilledwater.Thepelletswereresuspendedwith200lboiledH2O
and incubated at 95°C in a Thermomixer (Eppendorf) with strong agita-
tionfor5min,thesampleswerecentrifugedfor30minat10°C,andthe
supernatants were immediately used for pyruvate measurement using a
BioVisionpyruvateassaykitaccordingtothemanufacturer’sﬂuorescence
protocol. Fluorescence was measured using a Synergy HT multidetection
reader (excitation, 530 nm; emission, 590 nm).
RNA extraction and real-time PCR experiment. RNA was stabilized
using RNAprotect reagent (Qiagen), followed by extraction using an
RNeasy minikit (Qiagen) according to the manufacturer’s protocols. Re-
sidual DNA was digested using RQ1 RNase-free DNase (Promega), and
the samples were puriﬁed using the RNeasy cleanup procedure.
Five hundred nanograms of total RNA was reverse transcribed using
randomhexamers(Amersham)andImPromIIreversetranscriptase(Pro-
mega). Real-time PCRs for determination of gcp transcript levels were
performed using 500 nM primers GCAAATACCATTCGTGACAA and
TGCACTTAATCATCAGCGTAT in a 10-l volume with SYBR green
PCR master mix (Applied Biosystems). Reactions were run on a Rotor-
gene 6000 (Corbett) using the standard cycling parameters. Relative gene
expression data analysis was carried out by the CT method as described
in the manufacturer’s protocol (Corbett).
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